Teladoc Health, Inc. SEC filings TDOC

Teladoc Health, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 13, 2020. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.

Teladoc Health, Inc. SEC filings
Form Description Filed Period
3 Initial insider ownership Nov 3, 2026 Nov 2, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 8, 2026 —
4 Insider transaction Oct 5, 2026 Oct 1, 2026
8-K Current report
Officer or director change
Sep 25, 2026 Sep 24, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
144 Notice of proposed sale Sep 11, 2026 —
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
4 Insider transaction Sep 1, 2026 Sep 1, 2026
3 Initial insider ownership Sep 1, 2026 Aug 31, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 31, 2026 Aug 27, 2026
8-K Current report
Officer or director change
Aug 13, 2026 Aug 10, 2026
4 Insider transaction Aug 4, 2026 Aug 3, 2026
3 Initial insider ownership Aug 4, 2026 Aug 3, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 3, 2026 Aug 3, 2026
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
4 Insider transaction Jul 6, 2026 Jul 6, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jul 1, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 30, 2026 Jun 29, 2026
144 Notice of proposed sale Jun 29, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 22, 2026 —
4 Insider transaction Jun 12, 2026 Jun 10, 2026
144 Notice of proposed sale Jun 11, 2026 —
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 3, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
SD Specialized disclosure (conflict minerals) May 26, 2026 —
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 21, 2026
4 Insider transaction May 21, 2026 May 20, 2026
4 Insider transaction May 21, 2026 May 20, 2026
4 Insider transaction May 21, 2026 May 20, 2026
8-K Current report
Shareholder vote results
May 21, 2026 May 21, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
ARS Annual report to shareholders Apr 7, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 7, 2026 —
DEF 14A Proxy statement Apr 7, 2026 May 21, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 1, 2026 Mar 30, 2026
3 Initial insider ownership Apr 1, 2026 Mar 30, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 30, 2026 Mar 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4/A Form 4/a Mar 12, 2026 Feb 27, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
144 Notice of proposed sale Mar 11, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2022
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
4 Insider transaction Feb 19, 2026 Feb 18, 2026
3 Initial insider ownership Feb 19, 2026 Feb 18, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 18, 2026 Feb 18, 2026
8-K Current report
Officer or director change
Feb 12, 2026 Feb 8, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Dec 22, 2025 Dec 19, 2025
8-K Current report
Officer or director change
Dec 16, 2025 Dec 11, 2025
S-8 Employee stock plan registration Dec 12, 2025 —
8-K Current report
Officer or director change
Dec 12, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 10, 2025
144 Notice of proposed sale Dec 11, 2025 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 3, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
4 Insider transaction Nov 17, 2025 Nov 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Oct 23, 2025 Oct 17, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
4 Insider transaction Sep 22, 2025 Sep 19, 2025
4 Insider transaction Sep 11, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 11, 2025 —
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Sep 3, 2025 Aug 29, 2025
144 Notice of proposed sale Sep 3, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 29, 2025 Jul 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
8-K Current report
Material agreement, New debt
Jul 23, 2025 Jul 17, 2025
4 Insider transaction Jun 23, 2025 Jun 20, 2025
4 Insider transaction Jun 11, 2025 Jun 10, 2025
4 Insider transaction Jun 3, 2025 May 30, 2025
4 Insider transaction Jun 3, 2025 May 30, 2025
4 Insider transaction Jun 3, 2025 May 30, 2025
4 Insider transaction Jun 3, 2025 May 30, 2025
4 Insider transaction Jun 3, 2025 May 30, 2025
144 Notice of proposed sale Jun 3, 2025 —
144 Notice of proposed sale Jun 2, 2025 —
144 Notice of proposed sale Jun 2, 2025 —
144 Notice of proposed sale Jun 2, 2025 —
144 Notice of proposed sale Jun 2, 2025 —
144 Notice of proposed sale Jun 2, 2025 —
SD Specialized disclosure (conflict minerals) May 27, 2025 —
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 22, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 23, 2025 May 22, 2025
SCHEDULE 13G Ownership over 5% (passive) May 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
DEFA14A Additional proxy material May 5, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 30, 2025 Apr 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 24, 2025 —
4 Insider transaction Apr 8, 2025 Apr 4, 2025
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 Dec 31, 2024
144 Notice of proposed sale Apr 7, 2025 —
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 21, 2025 Mar 20, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
144 Notice of proposed sale Mar 21, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
144 Notice of proposed sale Mar 20, 2025 —
4 Insider transaction Mar 6, 2025 Mar 5, 2025
144 Notice of proposed sale Mar 5, 2025 —
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 10, 2025 —
144 Notice of proposed sale Jan 3, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
TDOC (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1477449
Former names
Teladoc, Inc. (until Aug 1, 2018)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.